Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area apoptosis bcl xl'

Search results for: 'research area apoptosis bcl xl'

Items 51-60 of 62

Page
per page
  1. VSV-G Peptide
    A6009 VSV-G Peptide
    Summary: Peptide sequence-YTDIEMNRLGK
      ≥134 mg/mL
  2. Radotinib(IY-5511)
    B5846 Radotinib(IY-5511)
    Target: PDGFR|Bcr-Abl
    Summary: Bcr-Abl tyrosine kinase inhibitor
      ≥13.73 mg/mL
  3. LY2090314
    A3570 LY2090314
    Target: GSK-3
    Summary: Potent GSK-3 inhibitor
      insoluble in H2O; ≥91 mg/mL
  4. Vorinostat (SAHA, MK0683)
    A4084 Vorinostat (SAHA, MK0683)
     9 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor
      insoluble in EtOH; insoluble in H2O; ≥4.41 mg/mL
  5. Puromycin aminonucleoside
    A3740 Puromycin aminonucleoside
     1 Citation
    Summary: Aminonucleoside portion of the antibiotic puromycin
      ≥14.45 mg/mL
  6. Tanshinone IIA
    N1846 Tanshinone IIA
    Target: AP-1|MAGL
    Summary: Antioxidant and anti-inflammatory reagent
      insoluble in EtOH; insoluble in H2O; ≥3.42 mg/mL
  7. Tofacitinib (CP-690550) Citrate
    A4135 Tofacitinib (CP-690550) Citrate
     2 Citation
    Target: JAK
    Summary: Potent JAK inhibitor
      ≥25.22 mg/mL
  8. BMS 309403
    B7794 BMS 309403
     2 Citation
    Target: Fatty-acid-binding proteins (FABPs)
    Summary: FABP4 inhibitor,potent and selective
      insoluble in H2O; ≥18.15 mg/mL
  9. Cucurbitacin I
    A4512 Cucurbitacin I
    Target: STAT|JAK
    Summary: STAT3/JAK2 signaling inhibitor
      ≥22.45 mg/mL
  10. AT13387
    A4056 AT13387
    Target: HSP90
    Summary: Hsp90 inhibitor
      insoluble in H2O; ≥13.25 mg/mL

Items 51-60 of 62

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 59item
  2. Natural Products 1 item
  3. Kits 1 item
  4. Peptides 1 item
  5. Peptides & Proteins 1 item
Reversibility
  1. Reversible 1 item
  2. Irreversible 4item
Target
  1. Caspases 9item
  2. Cyclin-Dependent Kinases 1 item
  3. Proteasome 1 item
  4. Cathepsins 1 item
  5. Histone Deacetylases (HDACs) 3item
  6. Inhibitor of apoptosis proteins (IAP) 2item
  7. Bcl-2 5item
  8. Raf 1 item
  9. Bcl-xl 3item
  10. MDM2 2item
  11. AP-1 1 item
  12. DT-diaphorases 1 item
  13. GSK-3 1 item
  14. VEGFR 2item
  15. PDGFR 2item
  16. c-Kit 1 item
  17. RET 1 item
  18. Mcl-1 3item
  19. JNK 1 item
  20. Bcr-Abl 1 item
  21. Deubiquitinating enzymes (DUBs) 1 item
  22. Smoothened 1 item
  23. Trk Receptors 1 item
  24. STAT 1 item
  25. RIP kinases 1 item
  26. JAK 3item
  27. HSP90 2item
  28. Survivin 1 item
  29. Ubiquitin-specific proteases 1 item
  30. Melanocortin (MC) Receptors 1 item
  31. Dehydrogenase 1 item
  32. MK2 1 item
  33. Fatty-acid-binding proteins (FABPs) 1 item
  34. COX 1 item
  35. NADPH Oxidases 1 item
  36. MAGL 1 item
  37. iNOS 1 item
  38. TRP Channel 1 item
  39. Apoptosis Inducers 1 item
  40. Cdc7 1 item
  41. angiogenesis 1 item
  42. PC-PLC 1 item
  43. PKD 1 item
  44. Bcl-w 1 item
Reported Experiments
  1. Animal Experiments 49item
  2. Cell Experiments 31item
Related Disease
  1. Acute Myeloid Leukemia 1 item
  2. Adrenocortical Carcinoma 1 item
  3. Autoimmune Diseases 1 item
  4. Breast Cancer 11item
  5. Cancer 37item
  6. Chronic Lymphocytic Leukemia 1 item
  7. Chronic Myeloproliferative Disorders 1 item
  8. Colon Cancer 5item
  9. Colon Carcinoma 1 item
  10. Colorectal Cancer 3item
  11. Glioblastoma 5item
  12. Hepatocellular Carcinoma 1 item
  13. Inflammatory Diseases 2item
  14. Leukemia 2item
  15. Lung Cancer 2item
  16. Lymphoma 4item
  17. Medulloblastoma 1 item
  18. Melanoma 5item
  19. Multiple Myeloma 1 item
  20. Myelofibrosis 1 item
  21. Myeloma 1 item
  22. Neuroblastoma 1 item
  23. Non-small Cell Lung Cancer 3item
  24. Ovarian Cancer 1 item
  25. Pain Relief 1 item
  26. Pancreatic Cancer 3item
  27. Pancreatic Carcinoma 1 item
  28. Prostate Cancer 8item
  29. Pulmonary Fibrosis 1 item
  30. Rheumatoid Arthritis 2item
  31. Soft Tissue Sarcoma 1 item
  32. Testicular Cancer 1 item
  33. Type 2 Diabetes 2item